Bao et al. have also confirmed that the high expression of FOXD2-AS1 is correlated with the poor prognosis of patients diagnosed with esophageal squamous cell carcinoma [20]. This evidence concerns the gene FOXD2 and esophageal squamous cell carcinoma.